ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1051

Identification of Differential Chromatin Accessibility Using ATAC-seq in a Novel 3D Tissue Culture System of Systemic Sclerosis

Tamar Wheeler1, Ji-Qing Chen 1, Diana Toledo 1, Bhaven Mehta 2, Yue Wang 2, Meredith Brown 1, Rajan Bhandari 3 and Mengqi Huang 4, 1Dartmouth College, Hanover, 2Geisel School of Medicine at Dartmouth, Hanover, NH, 3Dartmouth College, Lebanon, 4Geisel School of Medicine at Dartmouth College, Hanover, NH

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: epigenetics and 3D tissue model, Systemic sclerosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 11, 2019

Title: Systemic Sclerosis & Related Disorders – Basic Science Poster

Session Type: Poster Session (Monday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Although the majority of SSc research has focused on differential gene expression, recent studies havedemonstrated that non-coding epigenetic changes in chromatin accessibility are likely play a key role in SSc biology. In this study we developed a system for analyzing differentially accessible regulatory regions in SSc-derived cell lines using Assay for Transposase Accessible Chromatin with sequencing (ATAC-seq) in a novel 3D in vitro skin-like tissue model.

Methods: SSc and healthy control (HC) dermal fibroblast (FB) lines were isolated and expanded from skin biopsies. All patients met 2013 ACR/EULAR criteria for SSc.FBs were seeded in transwell chambers and cultured for 5 weeks to obtain self-assembled stromal (SAS) tissues in a simple 3D tissue model that recapitulates SSc biology. ATAC-seq was performed on both monolayer/2D fibroblast cultures and 3D tissues following tissue dissociation. ATAC-seq libraries were sequenced. Paired end reads were aligned to the hg19 reference genome and 300bp peaks were called in ZINBA. Data underwent quality control analyses and unsupervised hierarchal clustering. Genomic location of peaks was determined using ChIPseeker. The integrative genomics viewer (IGV) was used to analyze the genomic context of specific differentially accessible regions.

Results: ATAC-seq libraries contained a large number of reads (~30 million) and had comparable accessibility profiles to standard data sets (Fig. 1A-D). SSc FBs contained significantly more open chromatin (Fig. 1E) and the percentage of peaks within distal/intergenic regions was significantly higher than in HC FBs (Fig. 1F). In unsupervised hierarchal clustering of the top 50 differential 300bp peaks in both 2D and 3D tissues, SSc and HC tissues clustered by disease state. A differentially accessible region of significant interest was identified in both 2D and 3D individual heatmaps as well as a combined 2D/3D heatmap in which it was the only genomic peak which distinguished between SSc and HC samples (Fig. 1G). This region falls within an intron of a gene on chromosome 8 and contains a putative enhancer predicted to contain a binding site for the transcription factor STAT3.

Conclusion:

We were able to produce high quality data from both 2D and 3D cultures. Preliminary analysis of ATAC-seq data demonstrates that SSc fibroblasts maintain a distinct chromatin accessibility profile as compared to HC fibroblasts, characterized by increased global accessibility. The majority of these differentially accessibility peaks reside in genomic regions commonly associated with regulatory elements. Additionally, we were able to identify a region of significant interest containing a putative enhancer region and predicted binding site for STAT3, a transcription factor known to be dysregulated in SSc.


Disclosure: T. Wheeler, None; J. Chen, None; D. Toledo, None; B. Mehta, None; Y. Wang, None; M. Brown, None; R. Bhandari, None; M. Huang, None.

To cite this abstract in AMA style:

Wheeler T, Chen J, Toledo D, Mehta B, Wang Y, Brown M, Bhandari R, Huang M. Identification of Differential Chromatin Accessibility Using ATAC-seq in a Novel 3D Tissue Culture System of Systemic Sclerosis [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/identification-of-differential-chromatin-accessibility-using-atac-seq-in-a-novel-3d-tissue-culture-system-of-systemic-sclerosis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/identification-of-differential-chromatin-accessibility-using-atac-seq-in-a-novel-3d-tissue-culture-system-of-systemic-sclerosis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology